Neurofibromatosis is a genetic disorder that causes tumors to form in the central nervous system. While these tumors are typically benign, they can become malignant. Other complications of neurofibromatosis include hearing loss, learning impairment, vision loss, etc. Here is the latest research.

September 20, 2021

Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours.

Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis
Benjamin J Van TreeckSamar Said
September 20, 2021

A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas.

The Annals of Pharmacotherapy
Mary Kate AndersonZachery Halford
September 20, 2021
Case Report

Reconstruction of the chest wall after resection of malignant peripheral nerve sheath tumor: A case report.

World Journal of Clinical Cases
Xiang GuoYi Yang
September 20, 2021
Case Report
Open Access

Granulomatosis with polyangiitis and neurofibromatosis type 1: a fortuitous association? (a case report).

The Pan African Medical Journal
Berriche OlfaAlaya Wafa
September 18, 2021

Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey.

American Journal of Medical Genetics. Part a
Pamela L WoltersAna-Maria Vranceanu
September 18, 2021

Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.

Human Genetics
Hildegard Kehrer-Sawatzki, David N Cooper
September 18, 2021

Combined CDK inhibition overcomes MEK inhibitor resistance in plexiform neurofibroma of neurofibromatosis type I.

The Journal of Investigative Dermatology
Wei WangZhi-Chao Wang
September 17, 2021

Molecular characterization of pleomorphic mesothelioma: a multi-institutional study.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Somak RoySanja Dacic
September 17, 2021

Retrospective analysis of primary intraosseous malignancies in mandible and maxilla in a population of Taiwanese patients.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
Chih-Huang TsengYuk-Kwan Chen
September 17, 2021

R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.

Cell Communication and Signaling : CCS
Shannon M WeberSteven L Carroll
September 16, 2021

Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Journal of Neuro-oncology
Jordan JonesGabriel Dabscheck
September 16, 2021

Morbidity and Function Loss After Resection of Malignant Peripheral Nerve Sheath Tumors.

Enrico MartinMONACO collaborators
September 16, 2021
Open Access

Classical neurofibroma.

The Pan African Medical Journal
Pallavi Lalchand Harjpal, Rakesh Krishna Kovela
September 16, 2021
Case Report

A Huge Carotid Space Schwannoma Arising from The Cervical Sympathetic Chain - A Case Report.

Annals of Maxillofacial Surgery
Malek A ElsayedMohamed A Ellabban
September 16, 2021
Case Report

A Rare Case of Primary Pleural Neurofibroma.

Garima SharmaIpsit Ilahi
September 14, 2021
Open Access

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

MedRxiv : the Preprint Server for Health Sciences
A. K. MattoxChetan Bettegowda
September 15, 2021
Case Report

Histoid leprosy presenting as a large tumor.

Anais Brasileiros De Dermatologia
Tânia Rita Moreno de Oliveira FernandesAna Kívia Silva Matias
September 14, 2021
Case Report

Intradural Extramedullary Lesions in the Cervical Spine in Neurofibromatosis.

The American Journal of Case Reports
Rana Moshref, Abeer Mirdad
September 14, 2021

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells.

Journal of Visualized Experiments : JoVE
Jody Fromm LongoSteven L Carroll

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved